Diagnosis and therapy of Multiple Sclerosis

• 收藏
• 分享

专利权人:

PRINDEX S.R.L.

发明人:

Roberto Paterno,Mariarosaria Santillo,Vittorio Enrico Avvedimento,Luigi Michele Pavone

申请号：

US16857794

公开号：

US20200308251A1

申请日:

2020.04.24

申请国别(地区):

US

年份:

2020

代理人:

摘要：

The serotonin receptor 5HT2A (5HT2aR) and membrane NADPH oxidases (NOX enzymes) are found to be a target of autoantibodies present in Multiple Sclerosis patients. The present invention refers to peptides comprised in the extracellular regions of the human 5HT2aR and/or NOXs for diagnosis and therapy of Multiple Sclerosis.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/